Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study to Determine the Concentrations of Maraviroc in Semen, the Seminal to Plasma Ratio of Maraviroc and the Variability in Seminal to Plasma Ratios Over the Maraviroc Dosing Period.

Next Previous
Search
Trial Profile

Study to Determine the Concentrations of Maraviroc in Semen, the Seminal to Plasma Ratio of Maraviroc and the Variability in Seminal to Plasma Ratios Over the Maraviroc Dosing Period.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jul 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics

    • Most Recent Events

    • 13 Jun 2012 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 04 Jun 2012 Planned end date changed from 1 Jul 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov record.
    • 09 Dec 2009 Planned end date (1 Jul 2010) added as reported by ClinicalTrials.gov record (NCT01009034).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top